Microbiome Therapeutics Applications
-
Microbiological solutions for the metagenomic analysis of the microbiome industry
Microbe Inotech Laboratories, Inc. provides a microbial genomics platform through licensed database agreements focused on the characterization of microorganisms, pathogens and anti-microbial resistance for pathogen detection, food safety inspections and issues, pharmaceutical discovery, public health surveillance, water and wastewater analysis, agriculture and microbiome analysis and comparisons. From a post-sequencingmetagenomic sample (i.e. DNA extracted from your sample) the MiL Inc. provides identification ...
By Pluton Biosciences, Inc. based in St. Louis, MISSOURI (USA).
-
Microbiome Therapeutics for Patients and Physicians
Seres’ microbiome therapeutics represent a transformative new approach to ...
By Seres Therapeutics, Inc. based in Cambridge, MASSACHUSETTS (USA).
-
Microbiotica Solutions for Clinical Data and Sample Sets
Microbiotica is using best-in-class clinical data and sample sets coupled with its unrivalled microbiome profiling capability to progress best-in-class therapeutics and biomarkers. Microbiotica has programs in IBD, Immuno-oncology and Gut Epithelial Barrier Repair developing medicines and biomarkers based on microbiota. These programs start with deep metagenomic and culture-based analysis of patient samples and involve advanced bioinformatics and machine learning, to identify highly significant bacterial ...
By Microbiotica Limited based in Little Chesterford, UNITED KINGDOM.
-
Microbiome discovery solutions for human health sector
From Bench to Bedside and Back Again. Discovery Research: Diversigen is your comprehensive microbiome resource. Let us apply our extensive experience with highly diverse sample types, our scalable sequencing platforms, and exceptional bioinformatic capacity to help you find answers to your research questions. Our fast and reliable turnaround times, consistently high quality sequencing data and personalized customer service will give the confidence you need to move to the next step in your research ...
By Diversigen, Inc. based in New Brighton, MINNESOTA (USA).
-
Microbiome Therapeutics for Clinical Trials
Finch’s lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection (CDI), and has received Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration. In June 2020, Finch announced that CP101 met its primary efficacy endpoint in PRISM3, the first of two pivotal trials to support the development of CP101 for the prevention of recurrent CDI. PRISM4, a Phase 3 trial, is designed to serve as the second pivotal trial of ...
By Finch Therapeutics Group, Inc. based in Somerville, MASSACHUSETTS (USA).
-
Microbiome discovery solutions for environmental monitoring industry
Discover where our services can take you. Environmental Science: Microbial communities are critical components of virtually every ecosystem on the planet. Our assays allow for assessment and tracking of microbial community composition, diversity, and microbial function in diverse environmental sample ...
By Diversigen, Inc. based in New Brighton, MINNESOTA (USA).
-
Bioinformatics software solutions for metagenomics sector
Metagenomics is the study of all microbial genomes present in an environment, from the bottom of the sea to inside our own bodies. If you have shotgun NGS sequencing data, Partek provides powerful, easy-to-use analysis tools to characterize microbial ...
By Partek Incorporated based in Chesterfield, MISSOURI (USA).
-
Pharmaceutical Industry
By using our platform, we provide great opportunities for integrating metagenomic analysis into translational parts of pharmaceutical development. Our experience in metagenomic evaluation of large patient cohorts provides know-how and understanding regarding microbiome related conditions and can be applied for target evaluation, and for biomarker identification and development of subsequent patient stratification tools. The MetaboGen network contains clinicians specialized in various diseases, providing access to ...
By Metabogen AB based in Stockholm, SWEDEN.
-
Microbiota for Restoration Therapy
The influence of human gut microbiota on our health is an exciting and expanding frontier of research. New discoveries are published frequently underscoring the power and influence of these tiny organisms and their ecosystems over our every-day lives. Understanding this power, and how it can be harnessed to restore health or prevent disease, has been the guiding force for Rebiotix since its founding in ...
By Rebiotix Inc., a Ferring Company based in Roseville, MINNESOTA (USA).
-
Microbiota Based Product for Physician-Sponsored Studies
With the microbiota-based MRT™ drug platform, Rebiotix Inc., a Ferring Company, is on the forefront of a new era of medical ...
By Rebiotix Inc., a Ferring Company based in Roseville, MINNESOTA (USA).
-
Superfast real-time PCR solutions for antimicrobial resistance (AMR) stewardship sector
What is Antimicrobial Resistance (AMR)? Antimicrobial resistance is the ability of microbes to resist the effects of drugs – that is, the germs are not killed, and their growth is not stopped. Although some people are at greater risk than others, no one can completely avoid the risk of antibiotic-resistant infections. Infections with resistant organisms are difficult to treat, requiring costly and sometimes toxic ...
By OnsiteGene Inc. based in San Diego, CALIFORNIA (USA).
-
Medical diagnostics solutions for colorectal cancer sector
Colorectal cancer (CRC) is the third most common cancer all over the world. About 1.8 million new CRC cases were diagnosed globally in 2018, mostly in developed countries. The incidence of colorectal cancer is increasing in line with the ageing population. Early detection is key to successful treatment of the disease and related cost management. An efficient screening strategy is essential to detect the disease early, when it often does not produce symptoms. The currently available faecal occult blood test (FOBT) ...
By DiagNodus Ltd. based in Cambridge, UNITED KINGDOM.
-
Precision Therapeutics Platform
Locus has built an automated, generalizable platform that is systematically unlocking the power of bacteriophage and CRISPR-Cas3 across multiple therapeutic ...
By Locus Biosciences, Inc. based in Morrisville, NORTH CAROLINA (USA).
-
Microbiome discovery solutions for skin disease
High-accuracy skin microbiome profiling. Personalized Beauty & Cosmetics: Discover if your products are skin microbiome friendly. Create safer, more beneficial skin care products by understanding personal skin microbiome communities. Diversigen has optimized scalable sequencing and bioinformatic platforms to support personalized skin microbiome research – develop personal beauty and cosmetic products for improved skin ...
By Diversigen, Inc. based in New Brighton, MINNESOTA (USA).
-
Nanoparticle Concentration Analysis Devices for Extracellular Vesicles (EVs) Industry
Extracellular vesicles (EVs) are nano-sized lipid bilayer vesicles that are released by cells into the extracellular space.[1] EVs consist of proteins, polynucleic acids (e.g. RNA and DNA), and lipids, and can be divided into several subsets including exosomes (also known as small EVs), microvesicles, and apoptotic bodies (sometimes collectively known as large EVs). Fundamental differences exist between these different types of EVs based on how they are produced (biogenesis), their protein content, and their ...
By Dispertech B.V. based in Amsterdam, NETHERLANDS.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you